Stock Detail
PRANA BIOTECHNOLOGY LTD - AMERICAN DEPOSITARY SHARES EACH REPRESENTING TEN ORDINARY SHARES
Biotechnology
PRAN @ Yahoo Finance | PRAN Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $1.59 | $1.67 | $0.03 | 1.92% | 0.00 | $1.56 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $1.56 | $1.56 | 201,793 | 44.58M | 123,317 | -2.37 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.72 | 1.66 | 1.61 | 1.55 | 1.50 |
Stock Profile
Prana Biotechnology Limited, a development stage company, engages in the research and development of therapeutic drugs, which are designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses. The company primarily focuses on Alzheimer's disease, age-related cataracts, Creutzfeldt-Jakob disease, Motor Neuron disease, and Parkinson's disease. Its development stage products include PBT-1 and PBT-2, which will be used for the treatment of Alzheimer disease. The company was co-founded by Geoffrey Paul Kempler. Prana Biotechnology was incorporated in 1997 and is based in Parkville, Australia.